Showing results (1611-1620 of 2,364) with videos related to
Sort By:
Pageof 237
JACC. Cardiovascular Interventions|November 26, 2011
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized TrialsBimmer E Claessen, Pieter C Smits, Dean J Kereiakes, et al.The ISME Journal|May 5, 2019
Predictive genomic traits for bacterial growth in culture versus actual growth in soilJunhui Li, Rebecca L Mau, Paul Dijkstra, et al.Circulation. Cardiovascular Interventions|March 3, 2011
Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialBernhard Witzenbichler, Jochen Wöhrle, Giulio Guagliumi, et al.Journal of Thrombosis and Thrombolysis|September 28, 2010
Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudyCharles L Campbell, Steven R Steinhubl, William C Hooper, et al.JACC. Cardiovascular Interventions|May 25, 2015
Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)Gregg W Stone, Akiko Maehara, James E Muller, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 30, 2004
Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomesIoannis Iakovou, Roxana Mehran, George Dangas, et al.Journal of the American College of Cardiology|April 20, 2005
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trialStephen G Ellis, Jeffrey J Popma, John M Lasala, et al.BMC Medicine|September 28, 2024
Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trialJia Liao, Miaohan Qiu, Xiaojian Feng, et al.The American Journal of Cardiology|January 24, 2013
Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy)Roberto J Cubeddu, Igor F Palacios, James C Blankenship, et al.JACC. Cardiovascular Interventions|September 21, 2013
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)George D Dangas, Patrick W Serruys, Dean J Kereiakes, et al.Pageof 237